NCT07512934Recruiting
Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
Integrated Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes: a Cross-sectional Study Protocol
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
The goal of this observational study is to better understand how the pancreas works in adults with type 2 diabetes. The study focuses on both hormone production (endocrine function) and digestive function (exocrine function) of the pancreas. The main questions it aims to answer are: * Can problems with the pancreas help identify a different type of diabetes called pancreatogenic diabetes? * How are blood markers and pancreas structure related to pancreatic function? Participants will: * Have blood tests to measure glucose, insulin, and other markers * Provide a stool sample to assess digestive function * Undergo an ultrasound examination of the pancreas * Answer questions about digestive symptoms The study will take place during a single visit in outpatient clinics.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 310 (estimated)
- First submitted
- 25 Mar 2026
- Start date
- 7 Jul 2025
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- West Kazakhstan Marat Ospanov Medical University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07512934
What you commit to
- Study type: Observational
- Planned participants: 310
- From 7 Jul 2025 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- positive anti-glutamic acid decarboxylase antibodies (anti-GAD65);
- acute or chronic infections affecting metabolic status within the previous 4 weeks;
- previously diagnosed type 1 diabetes mellitus or other specific types of diabetes;
Other illness
- any history of malignant neoplasms;
- severe decompensated chronic diseases;
- conditions associated with systemic fibrosis (e.g., liver cirrhosis or autoimmune diseases);
Other
- pregnancy or lactation;
- refusal to participate.
Who the study is looking for
- • adult patients of Kazakh nationality aged 18 to 74 years
- diagnosis of T2DM established according to ADA criteria and documented in medical records
- disease duration ≤5 years
- absence of ketoacidosis episodes within the last 6 months
Age in the registry: 18 years to 74 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Outpatient clinics of Aktobe region, West Kazakhstan Marat Ospanov Medical University Coordinator of this site? Confirm its status | Aktobe | Kazakhstan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.